All Posts

Every year, thousands of women are told they have a suspicious ovarian mass. It's a sentence that changes everything in an instant, and for most of them, the only way to find out what it actually means is surgery. It's the part after that people are often surprised to learn. A large proportion of women who undergo surgery for a suspicious ovarian mass turn out not to have cancer at all [1]. The mass was benign. The surgery, with all its risks, recovery time and emotional weig

We're delighted to announce that Dr. David Herold, MD, PhD, has joined Proseek Bio as our first Clinical Advisor. It's a milestone moment for us. As we continue developing our blood test to help clinicians better assess suspicious ovarian masses, and work toward closing the diagnostic gap in women's health, having someone of David's calibre and experience guiding us is invaluable. About Dr. David Herold David brings decades of expertise in clinical pathology and mass spectrom

Proseek Bio is pleased to announce the appointment of Peter Bradley as Non-Executive Director. Peter brings extensive leadership experience across the biotechnology, medical technology, and life sciences sectors, with a strong track record of supporting innovation, commercial growth, and strategic development. His appointment strengthens Proseek Bio's Board as the company continues to advance diagnostics designed to improve earlier detection and clinical decision-making in ov